Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 20, 2008

View Archived Issues

Novel cPLA2 alpha inhibitor presented at the ACS meeting

GSK-189254 shows in vivo efficacy against neuropathic, but not inflammatory, pain

AS-006 effective in vivo against inflammatory pain

AMRI initiates phase I study of tubulin inhibitor ALB-109564(a) in advanced solid tumors

Watson successfully completes pilot clinical study of Stellar's Uracyst in interstitial cystitis

FDA and Medco sign partnership to study pharmacogenetic testing of prescription drugs

Omeros and Affitech enter agreement for fully human antibodies for MASP-2

Leo Pharmaceuticals receives European approval for Xamiol for scalp psoriasis

Repros presents an update on phase II endometriosis study of Proellex

Regeneron and Bayer HealthCare announce results from a phase II study of VEGF Trap-Eye

Allergan divulges new therapeutic agents for glaucoma in a recent patent

Recent Panacea Biotec patent discloses novel antibacterial agents

Schering-Plough launches asthma inhaler Asmanex Twisthaler in the U.S.

New agents for treating neurological disorders described in recent patent literature

Transplantation of islet cells with Sertoli cells may be feasible for diabetes treatment

Further PROMISE data show efficacy of voclosporin in renal transplantation

Pfizer's PDE10A inhibitor PF-254920 may be useful for the treatment of schizophrenia

Vical's Vaxfectin adjuvant to be tested with preventive DNA vaccine against HIV

Bristol-Myers Squibb and PDL enter global alliance in multiple myeloma

Cel-Sci enters exclusive licensing agreement with Teva for cancer drug Multikine

Neurologix starts recruitment in phase II gene transfer trial in Parkinson's disease

Viralytics doses second patient group in Cavatak phase I melanoma trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...